Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Open Book Extracts is a commercial-stage company specializing in the production of high-purity hemp-derived cannabinoids and custom formulations for the health and wellness sector. The company emphasizes research-backed innovation, quality control with pharma-grade specifications, non-GMO certification by A Greener World (AGW), NSF/ISO 9001/USDA Organic/Kosher certifications, and batch-to-batch consistency. It serves over 900 clients globally with both raw ingredients and finished goods but does not conduct clinical trials or have clinical results to report.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Open Book Extracts.